 |
市场调查报告书
商品编码
1488251
骨髓抽吸浓缩物市场 - 副产品（系统、配件）、应用（骨科手术、伤口癒合、血液癌、週边血管疾病、疼痛管理、血液癌）、最终用途（医院） - 全球预测 2024 - 2032 年Bone Marrow Aspirate Concentrates Market - By Product (Systems, Accessories), Application (Orthopaedic Surgery, Wound Healing, Blood Cancer, Peripheral Vascular Diseases, Pain Management, Blood Cancer), End-use (Hospitals) - Global Forecast 2024 - 2032 |
||||||
在该领域研发进步的推动下，2024 年至 2032 年间，全球骨髓抽吸浓缩物市场规模的复合年增长率将超过 5.4%。 BMAC 源自于患者的骨髓，含有间质干细胞和生长因子，使其成为各种骨科疾病和退化性疾病的有前途的治疗选择。例如，2021 年9 月，根据《美国运动医学杂誌》发表的研究，在骨髓抽吸浓缩物注射的帮助下，在改善膝骨关节炎(OA) 的疼痛和患者报告的结果方面取得了有希望的结果。
随着研究发现 BMAC 的新应用和治疗益处，医疗保健提供者和患者的兴趣日益浓厚。此外，探索 BMAC 在治疗骨关节炎和骨不连骨折等挑战性疾病方面的功效的临床试验进一步刺激了市场需求。 BMAC 领域的研究和开发日益受到关注，突显了其彻底改变再生医学和解决未满足的医疗需求的潜力。
整个骨髓抽吸浓缩物产业根据产品、应用、最终用途和地区进行分类。
骨髓抽吸浓缩物配件部分将在 2024 年至 2032 年期间经历严格的发展。 这些配件包括製备和管理 BMAC 注射液所需的专用套件、离心机和处理系统。随着 BMAC 手术在骨科和再生医学实践中越来越广泛采用，对这些配件的需求也相应增加。医疗机构和提供者寻求高效可靠的工具来优化 BMAC 的提取和应用，从而导致市场需求增加。这一趋势强调了配件在促进医疗中有效利用骨髓抽吸浓缩物方面的不可或缺的作用。
伤口癒合领域的骨髓抽吸浓缩物市场份额将在 2024 年至 2032 年实现显着的复合年增长率。其应用范围从慢性伤口到急性损伤，为具有挑战性伤口的患者提供了一个有前途的替代方案。随着医疗保健提供者越来越认识到 BMAC 在伤口管理方面的优势，对 BMAC 产品的需求不断增加。这项需求凸显了 BMAC 等创新再生疗法在解决伤口癒合和改善患者预后方面日益重要的重要性。
欧洲骨髓抽吸浓缩物市场将在2024 年至2032 年呈现出值得称讚的复合年增长率。需求。 BMAC 具有促进组织修復和再生的能力，引起了医疗保健提供者和患者的极大兴趣。此外，欧洲市场有利的监管环境和健全的医疗基础设施促进了 BMAC 程序的采用。因此，整个欧洲对 BMAC 产品和服务的需求显着增加，反映出该地区对再生医学的日益关注。
目录
第 1 章：方法与范围
第 2 章：执行摘要
第 3 章：产业洞察
- 产业生态系统分析
- 产业影响力
- 成长动力
- 骨科疾病盛行率上升
- 老年人口不断增加
- 扩大BMAC的应用范围
- 产业陷阱与挑战
- 治疗失败率高
- 与手术相关的高成本
- 成长动力
- 成长潜力分析
- 监管环境
- 技术景观
- 波特的分析
- PESTEL分析
- 未来市场趋势
第 4 章：竞争格局
- 介绍
- 公司矩阵分析
- 公司市占率分析
- 竞争定位矩阵
第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年
- 主要趋势
- 骨髓抽吸浓缩系统
- 骨髓抽吸浓缩配件
第 6 章：市场估计与预测：按应用划分，2018 年 - 2032 年
- 主要趋势
- 骨科手术
- 伤口癒合
- 周围血管疾病
- 疼痛管理
- 血癌
- 其他应用
第 7 章：市场估计与预测：按最终用途，2018 - 2032 年
- 主要趋势
- 医院和诊所
- 製药和生物技术公司
- CRO 和 CMO
- 学术及研究机构
- 其他最终用户
第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年
- 主要趋势
- 北美洲
- 我们
- 加拿大
- 欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
- 亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
- 中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区
第 9 章：公司简介
- Arthrex, Inc.
- Aspire Medical Innovation
- EmCyte Corporation
- Globus Medical, Inc.
- Isto Biologics
- MED & CARE - Innovative Solutions
- Ranfac Corporation
- Royal Biologics
- Scopio Labs
- Stryker Corporation
- Terumo Corporation
- Thermogenesis Holdings, Inc.
- Zimmer Biomet Holdings, Inc.
Global Bone Marrow Aspirate Concentrates Market Size will witness over 5.4% CAGR between 2024 and 2032, propelled by advancements in research and development within the field. BMAC, derived from a patient's bone marrow, contains mesenchymal stem cells and growth factors, making it a promising treatment option for various orthopedic conditions and degenerative diseases. For instance, in September 2021, according to research published in the American Journal of Sports Medicine, there were promising results in improving both pain and patient-reported outcomes in knee osteoarthritis (OA) with the help of bone marrow aspirate concentrate injections.
As research uncovers new applications and therapeutic benefits of BMAC, there is growing interest from healthcare providers and patients alike. In addition, clinical trials exploring the efficacy of BMAC in treating challenging conditions, such as osteoarthritis and non-union fractures, further fuel market demand. This rising focus on research and development in the BMAC field underscores its potential to revolutionize regenerative medicine and address unmet medical needs.
The overall Bone Marrow Aspirate Concentrates Industry is classified based on the product, application, end-use, and region.
The bone marrow aspirate concentrates accessories segment will undergo rigorous development from 2024 to 2032. These accessories include specialized kits, centrifuges, and processing systems required for the preparation and administration of BMAC injections. As BMAC procedures become more widely adopted in orthopedic and regenerative medicine practices, the demand for these accessories rises accordingly. Healthcare facilities and providers seek efficient and reliable tools to optimize the extraction and application of BMAC, leading to increased demand in the market. This trend underscores the integral role of accessories in facilitating the effective utilization of bone marrow aspirate concentrates in medical treatments.
The bone marrow aspirate concentrates market share from the wound healing segment will register a notable CAGR from 2024 to 2032. BMAC, rich in mesenchymal stem cells and growth factors, promotes tissue regeneration and accelerates the wound healing process. Its applications range from chronic wounds to acute injuries, offering a promising alternative for patients with challenging wounds. As healthcare providers increasingly recognize the benefits of BMAC in wound management, the demand for BMAC products rises. This demand underscores the growing importance of innovative regenerative therapies like BMAC in addressing wound healing and improving patient outcomes.
Europe bone marrow aspirate concentrates market will showcase a commendable CAGR from 2024 to 2032. Europe's aging population, coupled with a rising prevalence of orthopedic conditions and degenerative diseases, has propelled the need for effective regenerative treatments. BMAC, with its ability to promote tissue repair and regeneration, has garnered significant interest among healthcare providers and patients alike. Moreover, the European market's favorable regulatory environment and robust healthcare infrastructure have fostered the adoption of BMAC procedures. As a result, there is a notable increase in demand for BMAC products and services across Europe, reflecting the region's growing focus on regenerative medicine.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
- 1.5.2.1 Paid sources
- 1.5.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising prevalence of orthopedic disorders
- 3.2.1.2 Growing geriatric population
- 3.2.1.3 Widening applications of BMAC
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High failure rate of treatment
- 3.2.2.2 High cost associated with the procedure
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
- 3.7 PESTEL analysis
- 3.8 Future market trends
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive positioning matrix
Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Bone marrow aspirate concentrates systems
- 5.3 Bone marrow aspirate concentrates accessories
Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Orthopedic surgery
- 6.3 Wound healing
- 6.4 Peripheral vascular diseases
- 6.5 Pain management
- 6.6 Blood cancer
- 6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals & clinics
- 7.3 Pharmaceutical & biotechnology companies
- 7.4 CROs and CMOs
- 7.5 Academic & research institutes
- 7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Arthrex, Inc.
- 9.2 Aspire Medical Innovation
- 9.3 EmCyte Corporation
- 9.4 Globus Medical, Inc.
- 9.5 Isto Biologics
- 9.6 MED & CARE - Innovative Solutions
- 9.7 Ranfac Corporation
- 9.8 Royal Biologics
- 9.9 Scopio Labs
- 9.10 Stryker Corporation
- 9.11 Terumo Corporation
- 9.12 Thermogenesis Holdings, Inc.
- 9.13 Zimmer Biomet Holdings, Inc.
